Page last updated: 2024-11-05

1-methyl-5-chloro-4-nitroimidazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID21010
CHEMBL ID1610328
SCHEMBL ID3236045
MeSH IDM0065696

Synonyms (52)

Synonym
AKOS001116763
nsc7852
nsc-7852
1h-imidazole, 5-chloro-1-methyl-4-nitro-
imidazole, 5-chloro-1-methyl-4-nitro-
4897-25-0
5-chloro-1-methyl-4-nitro-1h-imidazole
pcmni
1-methyl-5-chloro-4-nitroimidazole
5-chloro-1-methyl-4-nitroimidazole
einecs 225-521-2
ai3-51948
s 50154-9
brn 0136775
5-chloro-1-methyl-4-nitroimidazole, 98%
smr000427350
MLS001049362
AC-11011
C1646
A7358
NCGC00246386-01
STK744422
1-methyl-4-nitro-5-chloroimidazole
BBL012664
unii-p917jw98bd
nsc 7852
p917jw98bd ,
HMS2797B15
AM20100205
azathioprine impurity c [ep impurity]
cmni
FT-0620216
1-methyl-4-nitro-5-chloro imidazole
SY020982
mfcd00233664
SCHEMBL3236045
a(s50154-9)
5-chloro-1-methyl-4-nitro-1h-imidazole #
W-106034
CHEMBL1610328
DS-0882
azathioprine ep impurity c
DTXSID00197646
azathioprine imp. c (ep); 5-chloro-1-methyl-4-nitroimidazole; azathioprine impurity c
5-chloro-1-methyl-4-nitro-1h-imidazole; azathioprine bp impurity c
EN300-13362
Q27286392
5-chloro-1-methyl-4-nitro imidazole
CS-0144974
PD014739
HY-W094047
Z57063140
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, 2-oxoglutarate OxygenaseHomo sapiens (human)Potency39.81070.177814.390939.8107AID2147
thioredoxin reductaseRattus norvegicus (Norway rat)Potency28.18380.100020.879379.4328AID588453
TDP1 proteinHomo sapiens (human)Potency29.09290.000811.382244.6684AID686978; AID686979
thioredoxin glutathione reductaseSchistosoma mansoniPotency3.98110.100022.9075100.0000AID485364
gemininHomo sapiens (human)Potency20.59620.004611.374133.4983AID624296
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's1 (7.69)18.2507
2000's0 (0.00)29.6817
2010's2 (15.38)24.3611
2020's4 (30.77)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.98 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.88 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]